ATE92476T1 - Kondensierte pyridazin-verbindungen und deren verwendung als arzneimittel. - Google Patents
Kondensierte pyridazin-verbindungen und deren verwendung als arzneimittel.Info
- Publication number
- ATE92476T1 ATE92476T1 AT88909359T AT88909359T ATE92476T1 AT E92476 T1 ATE92476 T1 AT E92476T1 AT 88909359 T AT88909359 T AT 88909359T AT 88909359 T AT88909359 T AT 88909359T AT E92476 T1 ATE92476 T1 AT E92476T1
- Authority
- AT
- Austria
- Prior art keywords
- different
- same
- action
- leucocytes
- alkyl
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical class C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 206010057249 Phagocytosis Diseases 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 230000008782 phagocytosis Effects 0.000 abstract 2
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 2
- 206010061598 Immunodeficiency Diseases 0.000 abstract 1
- 208000029462 Immunodeficiency disease Diseases 0.000 abstract 1
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- -1 hydroxy, nitro, amino Chemical group 0.000 abstract 1
- 230000007813 immunodeficiency Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 210000002540 macrophage Anatomy 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 150000004892 pyridazines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/36—Benzo-cinnolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27809987 | 1987-11-02 | ||
| JP24829588 | 1988-09-30 | ||
| EP88909359A EP0351435B1 (de) | 1987-11-02 | 1988-10-29 | Kondensierte pyridazin-verbindungen und deren verwendung als arzneimittel |
| PCT/JP1988/001109 WO1989004306A1 (fr) | 1987-11-02 | 1988-10-29 | Composes de pyridazine fusionnes et leurs utilisations medicales |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE92476T1 true ATE92476T1 (de) | 1993-08-15 |
Family
ID=26538701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88909359T ATE92476T1 (de) | 1987-11-02 | 1988-10-29 | Kondensierte pyridazin-verbindungen und deren verwendung als arzneimittel. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5045541A (de) |
| EP (1) | EP0351435B1 (de) |
| JP (1) | JP2623784B2 (de) |
| AT (1) | ATE92476T1 (de) |
| DE (1) | DE3882982T2 (de) |
| WO (1) | WO1989004306A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5339890A (en) * | 1993-02-08 | 1994-08-23 | Climate Master, Inc. | Ground source heat pump system comprising modular subterranean heat exchange units with concentric conduits |
| US20100210590A1 (en) * | 1995-09-27 | 2010-08-19 | Northwestern University | Compositions and treatments for seizure-related disorders |
| KR100360614B1 (ko) * | 1995-11-06 | 2003-06-02 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 1-아릴설포닐,아릴(티오)카르보닐-피리다지노유도체및제조방법 |
| GB9610893D0 (en) * | 1996-05-24 | 1996-07-31 | Astra Pharma Prod | Pharmaceutically useful compounds |
| US5723666A (en) * | 1996-06-21 | 1998-03-03 | Allergan | Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| WO1998009969A1 (en) * | 1996-09-05 | 1998-03-12 | Astra Pharmaceuticals Ltd. | Novel aryl-pyridazines |
| US20030176437A1 (en) | 2001-08-31 | 2003-09-18 | D.M. Watterson | Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| EP1812408B1 (de) | 2004-11-02 | 2013-10-09 | Northwestern University | Pyridazinverbindungen, zusammensetzungen und verfahren |
| WO2006050359A2 (en) * | 2004-11-02 | 2006-05-11 | Northwestern University | Pyridazine compounds and methods |
| WO2007127474A2 (en) * | 2006-04-28 | 2007-11-08 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
| BRPI0710938A2 (pt) * | 2006-04-28 | 2012-06-26 | Univ Northwestern | formulações contendo compostos de piridazina para o tratamento de doenças neuroinflamatórias |
| WO2007127448A2 (en) * | 2006-04-28 | 2007-11-08 | Northwestern University | Salts of pyridazine compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4602019A (en) * | 1983-04-22 | 1986-07-22 | Warner-Lambert Company | Indeno[1,2-c]pyridazin-3-one derivatives useful as cardiotonic and antihypertensive agents |
| GB2164643B (en) * | 1984-07-27 | 1988-11-02 | Boehringer Biochemia Srl | Tricyclic dihydropyridazinones and pharmaceutical compositions containing them |
| JPH06763B2 (ja) * | 1984-08-28 | 1994-01-05 | 吉富製薬株式会社 | ベンゾ〔ｈ〕シンノリン誘導体 |
| AU578496B2 (en) * | 1984-11-01 | 1988-10-27 | Smith Kline & French Laboratories Limited | Tricyclic heterocyclic compounds |
| JPH0633277B2 (ja) * | 1986-01-10 | 1994-05-02 | 吉富製薬株式会社 | ベンゾチオピラノ〔４，３−ｃ〕ピリダジン化合物 |
| DE3867086D1 (de) * | 1987-03-02 | 1992-02-06 | Yoshitomi Pharmaceutical | Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen. |
| JP2531687B2 (ja) * | 1987-07-01 | 1996-09-04 | 吉富製薬株式会社 | ベンズオキセピノ〔５，４−ｃ〕ピリダジン化合物 |
| JPH06147468A (ja) * | 1992-11-16 | 1994-05-27 | Sanden Corp | 気化式燃焼装置の制御方法 |
| JPH06156169A (ja) * | 1992-11-18 | 1994-06-03 | Mitsubishi Motors Corp | キャブオーバトラックのフロントグリル |
-
1988
- 1988-10-29 EP EP88909359A patent/EP0351435B1/de not_active Expired - Lifetime
- 1988-10-29 AT AT88909359T patent/ATE92476T1/de active
- 1988-10-29 US US07/391,603 patent/US5045541A/en not_active Expired - Fee Related
- 1988-10-29 WO PCT/JP1988/001109 patent/WO1989004306A1/ja not_active Ceased
- 1988-10-29 DE DE88909359T patent/DE3882982T2/de not_active Expired - Fee Related
- 1988-10-31 JP JP63275666A patent/JP2623784B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE3882982T2 (de) | 1993-11-25 |
| EP0351435A4 (de) | 1990-02-26 |
| JP2623784B2 (ja) | 1997-06-25 |
| EP0351435B1 (de) | 1993-08-04 |
| EP0351435A1 (de) | 1990-01-24 |
| JPH02167269A (ja) | 1990-06-27 |
| WO1989004306A1 (fr) | 1989-05-18 |
| US5045541A (en) | 1991-09-03 |
| DE3882982D1 (de) | 1993-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU913283D0 (en) | Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them | |
| ATE63742T1 (de) | Chinazolinon-derivate. | |
| OA09334A (fr) | "Dérivés d'acides aminés". | |
| DK0565549T3 (da) | Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B | |
| DE3882982D1 (de) | Kondensierte pyridazin-verbindungen und deren verwendung als arzneimittel. | |
| FR2384773A1 (fr) | Nouveaux composes heterocycliques a activite spasmolytique | |
| ES8707947A1 (es) | Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos. | |
| NO163568C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
| AU2868689A (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
| ATE22891T1 (de) | Pyrimidinonderivate und diese enthaltende pharmazeutische zusammensetzungen. | |
| NO882334L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO881835L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser. | |
| ATE126796T1 (de) | Quinazolinderivate und ihre herstellung. | |
| DK521685D0 (da) | Spergualin-derivater og anvendelse deraf til fremstilling af laegemidler med immunosuppressiv virkning | |
| PT861250E (pt) | Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase | |
| NZ231293A (en) | 1,2,3,4-tetrahydro-1,9-acridinediamines, homologues thereof, and pharmaceutical compositions | |
| PH24725A (en) | 9-amino-1,4-ethano-1,2,3,4-tetrahydrocridine and pharmaceutical composition and their use as medicaments | |
| ATE205209T1 (de) | Chinolincarbonsäurederivate und ihre salze | |
| FI864003A0 (fi) | Pyrido /1,2-a/ pyrimidinderivat, foerfaranden foer framstaellning daerav och dessa innehaollande farmaceutiska kompositioner foer behandling av allergiska sjukdomar. | |
| KR960703895A (ko) | 항균성 퀴놀리닐-(1H-1,2,4- 트리아졸-1-일) 알칸올 유도체(Antimicrobial quinolinyl-(1H-1,2,4-triazol-1-yl)alkanol derivatives) | |
| NO168707C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterotetracykliske laktamderivater. | |
| EP0204003A4 (de) | 2-(1-piperazinyl)-4-substituierte phenylchinolin-abkömmlinge. | |
| FR2694005B1 (fr) | Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. | |
| DK0784973T3 (da) | Quinoxalinderivater til behandling af tinnitus | |
| ATE57185T1 (de) | Pyrido(1,2-a>pyrimidinderivate. |